SATVI conducts TB vaccine clinical trials, and other general trials, which ensures the safety and effectiveness of new drugs or vaccines for treating, curing or preventing diseases. Clinical trials are conducted in phases amongst small groups of people in the early Phases (Phases I and II) and amongst larger groups of people once safety has been determined (Phases III and IV).

 

COVID-19 vaccine trials conducted at SATVI, 2020 - current
Protocol No.PopulationVaccine(s)20192020202120222023
NovavaxAdult population with and without HIV.

NVX-CoV2373

Clinicaltrials.gov:

Publications:

  
Ensemble (Janssen)Adults 18 and older.

Ad26.COV2>S

Clinicaltrials.gov:

bioRxiv:

Publications:

  
Sisonke Open Trial COVID-19Health workers aged 18 and above

Ad26.COV2.S COVID-19 vaccine

Clinicaltrials.gov:

Publications:

  
Sisonke Boost Open Label StudyHealth workers aged 18 and above

Ad26.COV2.S COVID-19 vaccine plus a homologous boostwith Ad26.COV2.S COVID-19 vaccine

Clinicaltrials.gov:

  
2 clinical trials, 2 novel COVID-19 candidates